Currently out of the existing stock ratings of Yale Jen, 51 are a BUY (98.08%), 1 are a HOLD (1.92%).

Yale Jen

Work Performance Price Targets & Ratings Chart

Analyst Yale Jen, currently employed at LAIDLAW, carries an average stock price target met ratio of 28.47% that have a potential upside of 40.66% achieved within 202 days.

Yale Jen’s has documented 94 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARCT, Arcturus Therapeutics Holdings at 22-Oct-2025.

Wall Street Analyst Yale Jen

Analyst best performing recommendations are on CRIS (CURIS).
The best stock recommendation documented was for CRIS (CURIS) at 12/8/2020. The price target of $200 was fulfilled within 31 days with a profit of $69 (52.67%) receiving and performance score of 16.99.

Average potential price target upside

of $36.85 (39.92%) on CRIS (CURIS).
of $26.6 (77.93%) on INAB (IN8BIO ).
of $22.11 (56.04%) on IONS (IONIS PHARMACEUTICALS).

ARCT Arcturus Therapeutics Holdings CRIS Curis VINC Vincerx Pharma IONS Ionis Pharmaceuticals EVFM Evofem Biosciences TCRT Alaunos Therapeutics SLNO Soleno Therapeutics AFMD Affimed NV EYPT Eyepoint Pharmaceuticals MEIP MEI Pharma BLPH Bellerophon Therapeutics ATNX Athenex ONTX Onconova Therapeutics SESN Sesen Bio ALDX Aldeyra The VKTX Viking Therapeutics EVOK Evoke Pharma INAB In8bio LIFE aTyr Pharma NLSP NLS Pharmaceutics AG OPK Opko Health RPRX Royalty Pharma Plc

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Mayank Mamtani (B. RILEY)